BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33858954)

  • 1. Evaluating meaningful levels of financial toxicity in gynecologic cancers.
    Esselen KM; Gompers A; Hacker MR; Bouberhan S; Shea M; Summerlin SS; Rucker LR; Huh WK; Pisu M; Liang MI
    Int J Gynecol Cancer; 2021 Jun; 31(6):801-806. PubMed ID: 33858954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.
    Liang MI; Pisu M; Summerlin SS; Boitano TKL; Blanchard CT; Bhatia S; Huh WK
    Gynecol Oncol; 2020 Feb; 156(2):271-277. PubMed ID: 31771866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
    Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.
    Liang MI; Harrison R; Aviki EM; Esselen KM; Nitecki R; Meyer L
    Gynecol Oncol; 2023 Mar; 170():317-327. PubMed ID: 36758422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
    Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
    J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer.
    Samuel CA; Spencer JC; Rosenstein DL; Reeder-Hayes KE; Manning ML; Sellers JB; Wheeler SB
    Breast Cancer Res Treat; 2020 Jan; 179(1):207-215. PubMed ID: 31555940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial toxicity assessment and associated factors analysis of patients with cancer in China.
    Qiu Z; Yao L; Jiang J
    Support Care Cancer; 2023 Apr; 31(5):264. PubMed ID: 37058171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
    Joyce DD; Schulte PJ; Kwon ED; Dusetzina SB; Moses KA; Sharma V; Penson DF; Tilburt JC; Boorjian SA
    J Urol; 2023 Aug; 210(2):290-298. PubMed ID: 37416955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors.
    Benedict C; Fisher S; Schapira L; Chao S; Sackeyfio S; Sullivan T; Pollom E; Berek JS; Kurian AW; Palesh O
    Psychooncology; 2022 Jan; 31(1):9-20. PubMed ID: 34224603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for financial toxicity in patients with gynecologic cancer.
    Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL; Broach V; Chi DS; Jewell EL; Leitao MM; Long Roche K; Mueller JJ; Sonoda Y; Zivanovic O; Gardner GJ; Abu-Rustum NR
    Am J Obstet Gynecol; 2022 Jun; 226(6):817.e1-817.e9. PubMed ID: 34902319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment.
    Green BW; Labagnara K; Feiertag N; Gupta K; Donnelly J; Watts KL; Crivelli JJ; Assimos DG; Small AC
    Urology; 2022 Dec; 170():46-52. PubMed ID: 36183747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients.
    Waters AR; Biddell CB; Killela M; Kasow KA; Page K; Wheeler SB; Drier SW; Kelly MS; Robles J; Spees LP
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30700. PubMed ID: 37776093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients.
    Liang MI; Dholakia JD; Lee GM; Wang L; Kako TD; Blair I; Williams CP; Arend RC; Huh WK; Rocque GB; Pisu M
    Gynecol Oncol; 2024 Apr; 183():53-60. PubMed ID: 38518528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and Validation of the Comprehensive Score for Financial Toxicity (COST) in a Population With Diabetes.
    Patel MR; Zhang G; Heisler M; Song PXK; Piette JD; Shi X; Choe HM; Smith A; Resnicow K
    Diabetes Care; 2022 Nov; 45(11):2535-2543. PubMed ID: 36048837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States.
    Albright BB; Nitecki R; Chino F; Chino JP; Havrilesky LJ; Aviki EM; Moss HA
    Am J Obstet Gynecol; 2022 Mar; 226(3):384.e1-384.e13. PubMed ID: 34597606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.